Metamaterial Exchangeco Inc.'s Parent Company Announces Distribution of Series C Preferred Stock

Yahoo FinanceJan 24 07:30

Metamaterial Exchangeco Inc. Announces Share Consolidation

Yahoo FinanceJan 24 05:05

Wall Street is getting more pessimistic! After Goldman Sachs Group downgraded the US GDP in the third quarter, Bank of America followed.

Original title: Wall Street is becoming more pessimistic! After Goldman Sachs Group downgraded the US GDP in the third quarter, Bank of America Corporation also followed the data and "speak with facts" source: with the continuous spread of Delta variants, the number of confirmed cases in the United States has increased rapidly, which has cast a shadow over the optimistic expectations of economic recovery. Goldman Sachs Group downgraded the US GDP twice in three weeks, followed by the US banking sector, and the latest data also confirmed that high growth is likely to be weak. Earlier this month, Goldman Sachs Group (Goldman Sachs) cut his US third-quarter GDP forecast to 5.5% from 9.0% due to d

FX168Aug 24, 2021 19:53

South Korea may prohibit Apple Inc and Alphabet Inc-CL C from drawing money from developers to create the world's first case.

Pindao, Aug. 24 (Xinhua)-- the legislative and judicial committee of South Korea's parliament is expected to approve an amendment to the telecom commerce law known as the Anti-Google Law on Tuesday, according to Sina Finance. App store operators such as Alphabet Inc-CL C and Apple Inc are prohibited from taking commission from developers' app purchases by taking advantage of their monopoly position. This will be the first time a major economy has imposed such restrictions. Alphabet Inc-CL C's Play app store generated nearly 6 trillion won ($5.29 billion) in revenue in South Korea in 2019, according to a government report released last year. Earlier this year, Alphabet Inc-CL C said that it would apply its Alphabet Inc-CL C Play app to developers.

品玩Aug 24, 2021 16:22

Bayer buys US biopharmaceutical company Vividion for $2 billion

Germany's Bayer Group announced on Thursday that it would buy US biopharmaceutical company Vividion Therapeutics for up to $2 billion to strengthen its ability to discover new treatments and increase the value of its drug pipeline. The deal is expected to close in the third quarter. Bayer will pay $1.5 billion first and up to $500m when Vividion's business reaches certain milestones in the future.

新浪財經Aug 5, 2021 14:06

Why Torchlight Energy Is Trading Lower Again Today

Benzinga Real-time NewsJun 23, 2021 22:00